ultragenyx pharmaceutical in
Eric W. Linsley CPA, MBA
Former Board Observer, Ultragenyx Pharmaceutical Inc.
|Age||Total Calculated Compensation||This person is connected to 159 board members in 6 different organizations across 16 different industries.|
See Board Relationships
Mr. Eric W. Linsley, CPA, MBA has been the Chief Financial Officer at Envisia Therapeutics Inc. since June 18, 2015. Previously, he was a Managing Partner at Pappas Ventures, where he was directly responsible for investments that led to several very successful acquisitions and public offerings. Prior to joining Pappas Ventures in 2000, he served as the Chief Financial Officer and Vice President of TriPath Imaging Inc. Mr. Linsley played a key role in the three-way merger ...
60 Leveroni CourtPhone: 415-483-8800
Novato, California 94949
Board Members Memberships*
Chairman of The Board
Director, Chairman of Audit Committee and Member of Compensation, Nomination & Governance Committee
New York University
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|